In DLBCL, MYC rearrangements typically involve the MYC gene translocating with immunoglobulin genes, such as immunoglobulin heavy chain (IGH), or immunoglobulin light chains (lambda, immunoglobulin light lambda chain and kappa, immunoglobulin light kappa chain), as well as non-immunoglobulin (non-IG) partner genes [26,27]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.